Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population

Benznidazole is the frontline drug used against Trypanosoma cruzi, the causative agent of Chagas disease. However, treatment failures are often reported. Here, we demonstrate that independently acquired mutations in the gene encoding a mitochondrial nitroreductase (TcNTR) can give rise to distinct d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mejia, Ana Maria, Hall, Belinda S., Taylor, Martin C., Gómez-Palacio, Andrés, Wilkinson, Shane R., Triana-Chávez, Omar, Kelly, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379838/
https://www.ncbi.nlm.nih.gov/pubmed/22551809
http://dx.doi.org/10.1093/infdis/jis331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379838/
https://www.ncbi.nlm.nih.gov/pubmed/22551809
http://dx.doi.org/10.1093/infdis/jis331

Ejemplares similares